Fematestanswer

Fematestanswer sells at-home diagnostic kits focused on female hormone and fertility testing. The single-use saliva or finger-prick tests sit in the mid-range price band—roughly US $79–$149 per kit—and are available only through the brand’s own website, with direct-to-consumer shipping across the United States. The kits are processed by CLIA-certified partner labs and promise physician-reviewed, numerical results within 5–7 days of the lab receiving the sample. Unlike general wellness panels, each kit targets a narrow female-hormone set—e.g., estradiol, progesterone, LH, FSH, AMH—so women can track ovulation windows or confirm perimenopause without a clinic visit. Primary buyers are 25- to 40-year-old women who cycle-track via apps, are either trying to conceive or postponing pregnancy, and prefer discreet, data-driven steps before seeing a specialist. The brand speaks to values of body literacy, time-saving convenience, and avoiding repeated clinic co-pays. Fematestanswer competes in the crowded at-home hormone test space populated by multi-panel “women’s health” startups and subscription fertility labs. It differentiates by keeping SKUs minimal, pricing below most mail-to-lab fertility bundles, and positioning itself strictly as a one-off, results-only service rather than an ongoing telehealth program.